M R Boyd

2.0k total citations
35 papers, 1.6k citations indexed

About

M R Boyd is a scholar working on Epidemiology, Pharmacology and Biochemistry. According to data from OpenAlex, M R Boyd has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 7 papers in Pharmacology and 7 papers in Biochemistry. Recurrent topics in M R Boyd's work include Herpesvirus Infections and Treatments (12 papers), Cytomegalovirus and herpesvirus research (9 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). M R Boyd is often cited by papers focused on Herpesvirus Infections and Treatments (12 papers), Cytomegalovirus and herpesvirus research (9 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). M R Boyd collaborates with scholars based in United Kingdom, United States and Australia. M R Boyd's co-authors include David Sutton, T. H. Bacon, Hènry A. Sasame, L T Burka, Martin Cole, Charles N. Statham, Earl R. Kern, Sharon Safrin, M. R. HARNDEN and Richard L. Jarvest and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M R Boyd

35 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M R Boyd United Kingdom 22 784 343 328 270 248 35 1.6k
Claire Guyomard France 14 557 0.7× 404 1.2× 372 1.1× 251 0.9× 86 0.3× 20 1.7k
Shimin Zhang United States 27 340 0.4× 641 1.9× 464 1.4× 320 1.2× 235 0.9× 82 2.0k
María A. Serrano Spain 33 427 0.5× 825 2.4× 295 0.9× 1.6k 6.0× 185 0.7× 103 3.1k
Grushenka H.I. Wolfgang United States 18 759 1.0× 219 0.6× 100 0.3× 108 0.4× 134 0.5× 37 1.4k
José Pedro Gil Sweden 34 293 0.4× 415 1.2× 900 2.7× 560 2.1× 501 2.0× 98 3.4k
Genta Kakiyama United States 26 969 1.2× 1.3k 3.7× 176 0.5× 640 2.4× 273 1.1× 64 2.4k
Patricia S. Watts United Kingdom 10 163 0.2× 230 0.7× 485 1.5× 261 1.0× 191 0.8× 10 1.2k
Christoph Reichel Germany 20 300 0.4× 603 1.8× 126 0.4× 587 2.2× 66 0.3× 57 2.0k
P. Carthew United Kingdom 28 161 0.2× 571 1.7× 231 0.7× 190 0.7× 120 0.5× 102 2.2k
D. C. Warhurst United Kingdom 25 283 0.4× 559 1.6× 280 0.9× 225 0.8× 209 0.8× 72 2.2k

Countries citing papers authored by M R Boyd

Since Specialization
Citations

This map shows the geographic impact of M R Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M R Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M R Boyd more than expected).

Fields of papers citing papers by M R Boyd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M R Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M R Boyd. The network helps show where M R Boyd may publish in the future.

Co-authorship network of co-authors of M R Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of M R Boyd. A scholar is included among the top collaborators of M R Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M R Boyd. M R Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sriram, Krishnan, M R Boyd, David T. Vistica, & S.R. Radhika Rajasree. (1997). In vitro neurotoxicity of the antitumor agent 9-methoxy-N2-methylellipticinium acetate (MMEA): role of brain cytochrome P-450.. PubMed. 18(1). 97–104. 2 indexed citations
2.
Bacon, T. H. & M R Boyd. (1995). Activity of penciclovir against Epstein-Barr virus. Antimicrobial Agents and Chemotherapy. 39(7). 1599–1602. 28 indexed citations
3.
Boyd, M R, Sharon Safrin, & Earl R. Kern. (1993). Penciclovir: a review of its spectrum of activity, selectivity, and cross-resistance pattern. Antiviral chemistry & chemotherapy. 4(6_suppl). 3–11. 121 indexed citations
4.
Boyd, M R, et al.. (1992). Effects of Penciclovir and Famciclovir in a Murine Model of Encephalitis Induced by Intranasal Inoculation of Herpes Simplex Virus Type 1. Antiviral chemistry & chemotherapy. 3(1). 37–47. 12 indexed citations
5.
Sutton, David, Jerry Taylor, T. H. Bacon, & M R Boyd. (1992). Activity of Penciclovir in Combination with Azido-Thymidine, Ganciclovir, Acyclovir, Foscarnet and Human Interferons against Herpes Simplex Virus Replication in Cell Culture. Antiviral chemistry & chemotherapy. 3(2). 85–94. 5 indexed citations
6.
Bailey, Stuart, M. R. HARNDEN, Richard L. Jarvest, Amy Parkin, & M R Boyd. (1991). Synthesis and antiviral activity of 9-alkoxypurines. 2. 9-(2,3-Dihydroxypropoxy)-, 9-(3,4-dihydroxybutoxy)-, and 9-(1,4-dihydroxybut-2-oxy)purines. Journal of Medicinal Chemistry. 34(1). 57–65. 30 indexed citations
7.
Hodge, R. Anthony Vere, David Sutton, M R Boyd, M. R. HARNDEN, & Richard L. Jarvest. (1989). Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]. Antimicrobial Agents and Chemotherapy. 33(10). 1765–1773. 158 indexed citations
8.
Boyd, M R, et al.. (1986). Improvement of the bioavailability of the anti-herpes virus agent BVDU by use of 5′-0-alkoxycarbonyl derivatives with increased metabolic stability. Journal of Antimicrobial Chemotherapy. 18(Supplement_B). 207–213. 3 indexed citations
9.
Kramer, Robert A., Hildegard M. Schuller, Adaline C. Smith, & M R Boyd. (1985). Effects of buthionine sulfoximine on the nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU).. Journal of Pharmacology and Experimental Therapeutics. 234(2). 498–506. 24 indexed citations
10.
Statham, Charles N., et al.. (1985). Effects of vitamin E on the distribution and metabolism of nitrofurantoin in rats.. Drug Metabolism and Disposition. 13(5). 532–534. 10 indexed citations
11.
Kramer, Robert A. & M R Boyd. (1983). Nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU) in the Fischer 344 rat.. Journal of Pharmacology and Experimental Therapeutics. 227(2). 409–414. 7 indexed citations
12.
Browne, Michael, et al.. (1983). Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance. Antimicrobial Agents and Chemotherapy. 23(3). 503–505. 12 indexed citations
13.
Statham, Charles N., et al.. (1983). Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system.. Journal of Pharmacology and Experimental Therapeutics. 224(1). 252–257. 26 indexed citations
14.
Statham, Charles N., et al.. (1982). Ipomeanol 4-glucuronide, a major urinary metabolite of 4-ipomeanol in the rat.. Drug Metabolism and Disposition. 10(3). 264–267. 9 indexed citations
15.
Boyd, M R & John S. Dutcher. (1981). Renal toxicity due to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse.. Journal of Pharmacology and Experimental Therapeutics. 216(3). 640–646. 28 indexed citations
16.
Buckpitt, Alan R. & M R Boyd. (1980). The in vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar aklylating agent and cytotoxin, 4-ipomeanol.. Journal of Pharmacology and Experimental Therapeutics. 215(1). 97–103. 30 indexed citations
17.
Boyd, M R, et al.. (1978). In vitro studies on the metabolic activation of the pulmonary toxin, 4-ipomeanol, by rat lung and liver microsomes.. Journal of Pharmacology and Experimental Therapeutics. 207(3). 677–686. 74 indexed citations
18.
Sasame, Hènry A. & M R Boyd. (1978). Paradoxical effects of cobaltous chloride and salts of other divalent metals on tissue levels of reduced glutathione and microsomal mixed-function oxidase components.. Journal of Pharmacology and Experimental Therapeutics. 205(3). 718–724. 93 indexed citations
19.
Harris, Stic & M R Boyd. (1977). The activity of iododeoxyuridine, adenine arabinoside, cytosine arabinoside, ribavirin and phosphonoacetic acid against herpes virus in the hairless mouse model. Journal of Antimicrobial Chemotherapy. 3(suppl A). 91–98. 17 indexed citations
20.
Boyd, M R, et al.. (1962). Human Influenza Viruses in Domesticated Animals. BMJ. 2(5297). 86–89. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026